Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Calmira AB
AB
Active
Org 5594226457
Upplandsgatan 45
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 825K
+204% vs 2023
EBITDA margin
19.4%
+88% vs 2023
Equity ratio
39.9%
Financial strength
Net profit 2024
SEK 96K
+43% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 825K
+204%
EBITDA
SEK 160K
+88%
Net profit
SEK 96K
+43%
Total assets
SEK 471K
+257%
Equity
SEK 188K
+104%
Employees
2
—
Company information
Legal name
Calmira AB
Org number
5594226457
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17 februari 2023
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Utveckling och försäljning av medicintekniska produkter.
Contact
Address
Upplandsgatan 45
Email
info@calmira.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
271
825
Staff expenses
—
—
EBITDA
85
160
Depreciation & amort.
−0
—
EBIT
85
160
Net financials
—
−0
Profit before tax
84
120
Tax
−17
−25
Net profit
67
96
Balance sheet
SEK thousands
Item
2023
2024
Total assets
132
471
Equity
92
188
Long-term debt
0
—
Short-term debt
40
244
Total debt
40
244
Financial ratios
5-year trend
EBITDA margin
19.4%
This company
15.8%
Market median
+23% vs market
2023
2024
Equity ratio
39.9%
This company
38.2%
Market median
+4% vs market
2023
2024
Return on equity
50.9%
This company
18.4%
Market median
+177% vs market
2023
2024
Net profit margin
11.6%
This company
8.1%
Market median
+43% vs market
2023
2024
Asset turnover
1.75×
This company
1.12×
Market median
+56% vs market
2023
2024
Debt / equity
1.51×
This company
0.62×
Market median
-144% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-02-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
PO
Per Olov Gottfrid Holmertz
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
BR
Bengt Reinhold Eddeland
Chairman
2024
CS
Carl Stefan Hans Friman
Deputy Board Member
2024
Former (2)
PJ
Per Jonas Sigfrid Setterberg
Chairman
2023 – 2024
AE
Anna Emilie Setterberg
Deputy Board Member
2023 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Calmira AB also hold positions in
0
other companies.
Person
Role here
Other companies
Per Olov Gottfrid Holmertz
Chief Executive Officer
0 companies
Bengt Reinhold Eddeland
Chairman
0 companies
Carl Stefan Hans Friman
Deputy Board Member
0 companies
Per Jonas Sigfrid Setterberg
Chairman
0 companies
Anna Emilie Setterberg
Deputy Board Member
0 companies